Insider Financial icon

With Covid Uncertainty Looming, is Pfizer a Buy for 2023?

With Covid Uncertainty Looming, is Pfizer a Buy for 2023?

Covid is Still a Global Problem The price of Pfizer stock is declining in the opening days of January as analysts prepare for the anticipated failure of the Covid vaccination and antiviral medication this year. After a Bank of America Securities analyst downgraded Pfizer shares on January 4, shares fell (PFE). In contrast to analysts…